Enanta hits new highs as Leerink gets bullishNov. 27, 2013 3:49 PM ET|About: Enanta Pharmaceuticals, Inc. (ENTA)|By: Colin Lokey, SA News Editor Shares of Enanta (ENTA +6.7%) are hitting new highs today on above average volume. Helping the cause is Leerink, where analysts have upgraded the shares to Outperform. Price target is $29. See also: AbbVie reports SAPPHIRE-1 HCV results.